Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ENB-0040 in Children with Hypophosphatasia
NCT00894075Phase 2Withdrawn
- Sponsor
- Alexion Pharmaceuticals
- Start
- Jul 2009
- Primary completion
- Dec 2014
- Modality
- Replacement Enzymes
01
Overview
A Phase 2 trial of asfotase alfa in hypophosphatasia (HPP), sponsored by Alexion Pharmaceuticals. Planned start Jul 2009; status: withdrawn.
02
Drugs
asfotase alfa
03
Conditions
hypophosphatasia (HPP)
Beyond the preview
Go deeper on NCT00894075.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00894075.